Oxy Capital is a multi-strategy investment firm with a focus on both private equity and public markets. In private equity, they target mature Portuguese SMEs for acquisition and transformation, focusing on special situations, operational turnarounds, and growth opportunities. Their public market "Liquid Opportunities" strategy concentrates on European small-cap equities, utilizing a private equity-like approach with in-depth research, concentrated portfolios, long-term value focus, and active engagement with management teams.
33% of their portfolio is in Healthcare. Deal activity decreased year-over-year (1 deals in the last 12 months vs 2 prior). Their most common stage is series-a (67% of deals). Average disclosed round size is $18.5M (across 3 rounds with reported amounts).
Portfolio
3
Fund Size
$1.6B
Top Stage
Series A
Last 12 Mo
1
Portfolio Breakdown
Stage Distribution
Sector Distribution
Investment Activity
Portfolio
| Company | Round | Amount | Date |
|---|---|---|---|
 Sword Health | Series B | $40M | Jun 2025 |
| AAutomaise | Series A | $5M | Mar 2025 |
 IOTA Software Inc. | Series A | $10.4M | Oct 2024 |
Top Co-Investors
Last updated: 16 April 2026